The trial of a coronavirus vaccine from China’s CanSino Biologics has been successfully completed at Lahore’s University of Health Sciences. No severe reactions have been reported. Only 5% of those vaccinated experienced a mild fever after being administered the shots, according to UHS Vice Chancellor Professor Javed Akram. Clinical trials of the same vaccine recorded no severe adverse effects as well, CanSino’s Chief Scientific Officer Zhu Tao said in September 2020. Mild reactions included fever, fatigue, and soreness at the injection site. In Lahore’s trial, 60% of those listed were men and the remaining 40% women. All volunteers were over 18 years of age. Professor Ak
Hence then, the article about lahore cansino vaccine trial concludes with no severe reactions reported was published today ( ) and is available onsamanews ( palestine ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Lahore CanSino vaccine trial concludes with no severe reactions reported )